Use Of Restricted Mean Survival Time In The Presence Of Non-Proportional Hazards As An Alternative Measure Of Treatment Benefit In Cost-Effectiveness Analyses
VALUE IN HEALTH(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
VALUE IN HEALTH(2021)